Lanreotide vs. Octreotide-LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Observational Time and Motion Analysis Article
Web of Science: 000462541800105
Industry Collaboration
International Collaboration